RSLS - ReShape Lifesciences gets notice of allowance for additional U.S. patent
2024-03-28 08:56:46 ET
More on ReShape Lifesciences
- ReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut plan
- Seeking Alpha’s Quant Rating on ReShape Lifesciences
- Historical earnings data for ReShape Lifesciences
- Financial information for ReShape Lifesciences